Contamination causing infection is one possible risk; the likelihood depends on the preparation and procedure. Another concern is spending time and money on an intervention with no meaningful benefit while delaying effective care. Ask how quality, monitoring and alternatives are assessed. US FDA: regenerative medicine patient information. Our safety guide separates product, procedure and patient factors.
On this page
Ask about likelihood and consequences
A risk list alone cannot tell you whether a proposal is reasonable. Discuss the likelihood, severity and uncertainty of each important concern, then compare them with the likely benefit and alternatives. Find out how problems would be detected and managed. An intervention described as natural still needs this assessment.
Questions to take to a consultation
- What safety data match this preparation and route?
- How large was the population studied?
- What emergency and follow-up arrangements are in place?
Request clear written answers and discuss unresolved points with a clinician familiar with your history before committing to a product or procedure.
Related questions
- What are the negative side effects of stem cell therapy?
- Can stem cells turn cancerous?
- Who is not a candidate for stem cell therapy?
Return to the FAQ index to browse all questions and the detailed decision guides.
Ask about an assessment
For questions about the review process, availability or a written estimate, message Thailand Stem Cell Clinic. Ask how to share records securely. An enquiry does not confirm eligibility or that a particular treatment is offered.
All FAQs · Treatment guides · Contact information
Sources and further reading
General information, not an individual medical recommendation. Prices, coverage, eligibility and authorisation require case-specific confirmation. Source links describe their own research and jurisdictions.